Ma Xing Shi Gan Decoction Attenuates PM2.5 Induced Lung Injury via Inhibiting HMGB1/TLR4/NFκB Signal Pathway in Rat
Ma Xing Shi Gan Decoction (MXD), a classical traditional Chinese medicine prescription, is widely used for the treatment of upper respiratory tract infection. However, the effect of MXD against particulate matters with diameter of less than 2.5 μm (PM2.5) induced lung injury remains to be elucidated...
Saved in:
Main Authors: | Yu-xiang Fei (Author), Bo Zhao (Author), Qi-yang Yin (Author), Yan-ying Qiu (Author), Guang-hui Ren (Author), Bo-wen Wang (Author), Ye-fang Wang (Author), Wei-rong Fang (Author), Yun-man Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Network Pharmacology Study on the Effects of Ma Xing Shi Gan Decoction on Influenza
by: Long Xi, et al.
Published: (2020) -
Systematic Pharmacological Strategies to Explore the Regulatory Mechanism of Ma Xing Shi Gan Decoction on COVID-19
by: Zhang Shi-Ying, et al.
Published: (2020) -
Pharmacological mechanisms of Ma Xing Shi Gan Decoction in treating influenza virus-induced pneumonia: intestinal microbiota and pulmonary glycolysis
by: Lin Jiang, et al.
Published: (2024) -
Deciphering the Pharmacological Mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through Integrating Network Pharmacology and Experimental Exploration
by: Qianqian Li, et al.
Published: (2020) -
The rational dose for MaXingShiGan decoction is crucial for its clinical effectiveness in treating bronchial pneumonia: three randomized, double-blind, dose-parallel controlled clinical studies
by: Xuedong An, et al.
Published: (2023)